<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BD961B8D-8BA7-45AE-80A9-E29741D7C740"><gtr:id>BD961B8D-8BA7-45AE-80A9-E29741D7C740</gtr:id><gtr:name>Duke-NUS Graduate Medical School</gtr:name><gtr:address><gtr:line1>8 College Road</gtr:line1><gtr:line2>Level 8</gtr:line2><gtr:postCode>169857</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8A72CAED-BA23-4191-9534-892865CC3539"><gtr:id>8A72CAED-BA23-4191-9534-892865CC3539</gtr:id><gtr:name>Paul Ehrlich Institut</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Medicine Dentistry and Biomedical Sci</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BD961B8D-8BA7-45AE-80A9-E29741D7C740"><gtr:id>BD961B8D-8BA7-45AE-80A9-E29741D7C740</gtr:id><gtr:name>Duke-NUS Graduate Medical School</gtr:name><gtr:address><gtr:line1>8 College Road</gtr:line1><gtr:line2>Level 8</gtr:line2><gtr:postCode>169857</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8A72CAED-BA23-4191-9534-892865CC3539"><gtr:id>8A72CAED-BA23-4191-9534-892865CC3539</gtr:id><gtr:name>Paul Ehrlich Institut</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CC56CEB6-29AA-444A-8689-4C70122AB699"><gtr:id>CC56CEB6-29AA-444A-8689-4C70122AB699</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Duprex</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/53F4798C-3079-4801-AF37-F70368EEAA71"><gtr:id>53F4798C-3079-4801-AF37-F70368EEAA71</gtr:id><gtr:firstName>Bertus Karel</gtr:firstName><gtr:surname>Rima</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E759D453-32B9-47F3-95A9-86E0F239A624"><gtr:id>E759D453-32B9-47F3-95A9-86E0F239A624</gtr:id><gtr:firstName>Rik</gtr:firstName><gtr:surname>de Swart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E07E4047-B87F-475D-849B-2382DEBF9DD3"><gtr:id>E07E4047-B87F-475D-849B-2382DEBF9DD3</gtr:id><gtr:firstName>ADME</gtr:firstName><gtr:surname>Osterhaus</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801001"><gtr:id>2ED2FD6C-6C6E-44F4-AC94-B6C2054F81E0</gtr:id><gtr:title>Illuminating childhood respiratory infections: from viral diseases to vaccine delivery</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801001</gtr:grantReference><gtr:abstractText>Chickenpox and shingles, severe diarrhoea, cervical cancer, meningitis - a diverse assortment of very different diseases which affect young and old; rich and poor; people who live in developed and developing parts of the world. However, what unites this conglomeration of conditions is that in the last couple of years several major pharmaceutical companies have released new vaccines to fight these diseases. ?Vaccines are back?, but in reality they never went away, rather they ?kept their heads down? and delivered. Few products have done more to alleviate disease than vaccines. Moreover, vaccines continue to provide a steady source of income for the companies as other manufacturers who rely on selling low cost generic drugs find them harder to replicate.

The aim of this project is to understand how respiratory viruses cause disease by using and extending an animal model in which monkeys are infected with the virus that causes measles. However, not just any measles virus, rather we plan to use a genetically modified virus which glows bright green when it infects a cell. This allows us to light up disease in a hitherto impossible manner. When you think of measles in a child you probably think of red spots - when you think of measles in our monkey model ? think green! Green spots, green tonsils and green patches along the windpipe and in the lungs. As well as seeing these illuminated manifestations of disease by eye high powered microscopes can be used to identify individually infected cells with supreme levels of sensitivity. Since this animal model has been so beneficial for measles research we plan to use it to study how two other respiratory viruses establish infections by making them ?genetically green?. 

It is essential to understand viral diseases comprehensively. This will help break down some of the barriers which get in the way of developing new vaccines. Already we have noticed that the tonsils are targeted in the very early of a measles virus infection. Therefore, with the help of industrial scientists, we will remove all of the water from vaccine and turn it into a solid which quickly melts on contact with saliva. We plan to take these vaccine-melts and place them directly onto the tonsils of the animal. Vaccinating in this way is much more natural than using a syringe to inject a respiratory virus into the arm. This may allow us to make better vaccines.</gtr:abstractText><gtr:technicalSummary>We propose a multidisciplinary, integrated programme of work which aims to alleviate bottlenecks which hamper translation of fundamental knowledge into vaccine development. The work is based on our recently published measles/non-human primate pathogenesis model and we plan to identify common pathways of transmission for respiratory viruses. This information will be used to evaluate new routes of vaccine administration and the approach will be piloted by delivering lyophilised measles virus (MV) vaccine directly to the tonsils of the macaque.

The pleomorphic nature of paramyxovirus virions allows them to be engineered to carry extra genetic material which is stably maintained over many passages. Reverse genetics has allowed additional transcription units to be added before, between and after paramyxoviral genes. Open reading frames encoding reporter proteins such as enhanced green fluorescent protein (EGFP) have been used extensively and a significant amount of EGFP is expressed when cells are infected. Fluorescence allows infected cells to be visualised at unprecedented levels of sensitivity both in vitro and in vivo. As EGFP makes the entire cytoplasm of the cell fluorescent it is possible to visualise fine processes which interconnect cells. Therefore these viruses are perfectly suited for the study of virus transmission and pathogenesis.

The MV model will be extended to two other paramyxoviruses, human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV), which are associated with significant levels of morbidity and mortality. It has been difficult to develop vaccines against these viruses and to move forward it is essential to underpin future product development with a comprehensive understanding of the infections. Complementary whole animal, ex vivo and in vitro assays will be developed. Experimental observations will be cross-validated with pathological samples from naturally infected patients using a panel of human tissues from children infected with wild-type MV, a range of hMPV and hRSV clinical isolates from the UK and MV isolates from Africa. Currently circulating clinical isolates will be used to validate both in vivo and ex vivo assays.

This multidimensional model of disease provides an ideal platform to understand general pathogenesis of respiratory viruses. If we are able to elicit a solid immune response by tonsillar delivery tissue we will follow up this application with another in which we undertake challenge experiments. This is important as it has been recognised by MRC that, ?here are still many gaps in knowledge about how protective immune responses are generated and regulated in mucosal tissues?.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>879113</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam (Erasmus Universitair Medisch Centrum EUR)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center</gtr:department><gtr:description>Erasmus Medical Center</gtr:description><gtr:id>38B46546-EDE6-4337-AE0E-4AF4DAF5DC6E</gtr:id><gtr:impact>This collaboration enabled me to make an application to the Bill and Melinda Gates Foundation Grand Challenges in Global Health Initiative/Foundation of the National Institutes for Health which has recently been funded.</gtr:impact><gtr:partnerContribution>This partnership has allowed us access to a macaque model of measles virus pathogenesis which is not available in the United Kingdom. Scientists from Rotterdam participate in small animal experimentation in The Queen's University of Belfast (QUB) and have been instrumental in developing our immunological capabilities.</gtr:partnerContribution><gtr:piContribution>We have provided all of the recombinant viruses which have been used extensively in the monkey model. We host visitors from Rotterdam at QUB, where we train them in bioimaging, immunohistochemisty and pathological assessements.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of W?rzburg (Universit?t W?rzburg)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Virology and Immunobiology W?rzburg</gtr:department><gtr:description>University of W&amp;uuml;rzburg</gtr:description><gtr:id>E8F34201-70E8-40E4-8046-57ACA87EE2C3</gtr:id><gtr:impact>I have a rolling visiting professorship which is sponsored by Sonderforschungsbereich 479 (an interdisciplinary integrated twelve year programme of work funded by the Deutsche Forschungsgemeinschaft (DFG). This enables me to spend between two to four weeks working in W&amp;uuml;rzburg each year. As a result of this, alongside the establishment of the International Graduate Centre in the University of W&amp;uuml;rzburg, I now co-supervise three PhD students who work in the Institute who are supported by the DFG.</gtr:impact><gtr:partnerContribution>We organise an annual, invitation only, European Measles Virus Workshop in W&amp;uuml;rzburg. There we critique data, share ideas, formulate strategy and distribute reagents to help facilitate the ongoing programmes of work in the partner laboratories.</gtr:partnerContribution><gtr:piContribution>We have provided many recombinant viruses which have been used extensively. We host visitors from W&amp;uuml;rzburg in The Queen's University of Belfast and train them in reverse genetics technologies, pathological assessment and bioimaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke-NUS Graduate Medical School</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Microbiology Duke-NUS</gtr:department><gtr:description>Duke University and Paul Ehrlich Institut</gtr:description><gtr:id>A6BA3545-A8C5-4978-8B59-22FFA055D60B</gtr:id><gtr:impact>mutlidisciplinary (virology, cell biology and automation technologies).</gtr:impact><gtr:partnerContribution>Providing access to high content screening platform of siRNAs against all known and putative human genes.</gtr:partnerContribution><gtr:piContribution>We are providing the recombinant measles, mumps and respiratory syncytial clinical isolates and will develop a high content screen to look for host factors which restrict or promote paramyxovirus infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Paul Ehrlich Institut</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Veterinary Medicine</gtr:department><gtr:description>Duke University and Paul Ehrlich Institut</gtr:description><gtr:id>F6A5FE2D-EF72-468C-BA67-C282A6E58802</gtr:id><gtr:impact>mutlidisciplinary (virology, cell biology and automation technologies).</gtr:impact><gtr:partnerContribution>Providing access to high content screening platform of siRNAs against all known and putative human genes.</gtr:partnerContribution><gtr:piContribution>We are providing the recombinant measles, mumps and respiratory syncytial clinical isolates and will develop a high content screen to look for host factors which restrict or promote paramyxovirus infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Harvard Medical School, Harvard University</gtr:description><gtr:id>EE4C0F8B-964A-4877-803F-0668D409DA4F</gtr:id><gtr:impact>Paper in preparation.</gtr:impact><gtr:partnerContribution>Our collaborator, Michaela Gack (HMS), has used the viruses we generate to dissect the role of the PPD-1 pathway in dendritic cells.</gtr:partnerContribution><gtr:piContribution>We are using the systems developed to generate recombinant viruses which can be used to dissect how the virus interefers with the inate immune response on a mechanistic level.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SGM Blog Interview at ESV Meeting</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9712252-09CF-41BD-987E-2DC0E0DA359F</gtr:id><gtr:impact>I was interviewed by the SGM for their monthy blog: Microbe Post

Twitter interest (@10queues)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://microbepost.org/2013/11/11/microbe-talk-november-2013/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SCIART</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D4891220-F85F-4052-BA15-A7D1B84E9C4A</gtr:id><gtr:impact>Under the auspices of the University's Bioimaging Core Technology Unit, of which I am co-academic lead, we host final year students from St. Mary's University College (191 Falls Road, Belfast, Northern Ireland) who take inspiration from photomicrographs produced using our confocal and electron microscopes. Thereafter the students produce a range of art works, some of which are on display in the unit.

The Head of the Art Department at St. Mary's presented a paper entitled, &amp;quot;An exploration of SCIART in various educational contexts&amp;quot;, at the 32nd National Microscopical Society of Ireland conference, which was held in The Queen's University of Belfast.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>This Week in Virology #286</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7F7F7F5F-41F8-4608-A015-79D8DC721B31</gtr:id><gtr:impact>This Week in Virology (TWiV) is the most widely listened to virology podcast in the world. It has international reach and is listened to by both professional scientists and the general public.

Significant number of colleagues and press follow up. Excellent recruiting tool for PDRAs</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.twiv.tv/2014/05/25/twiv-286-boston-twiv-party/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Northern Ireland Multipe Sclerosis Society</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D1387733-92EF-4E03-8789-82C3AE75AEB0</gtr:id><gtr:impact>We hosted representitatives from the Multipe Sclerosis Society in Northern Ireland who toured the bioimaging facilities in the University and met with scientists undertaking MS related research.

This visit consolidated the University's already strong relationship with the MS Society and they appreciated how the funds they had contributed to purchase a state-of-the art confocal microscope had allowed the development of a vibrant bioimaging community within the University.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Foundation for NIH Grand Challenges in Global Health</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>416BE381-03C7-4CED-A87A-6F531FDF8692</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>59863</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capacity Building Area Studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>55B748F5-2937-4783-8F08-8C09AADAB340</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department for Employment and Learning Northern Ireland (DELNI)</gtr:department><gtr:description>DELNI Strengthening the All-Ireland Research Base</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Government of Northern Ireland</gtr:fundingOrg><gtr:id>CFB813F7-14C2-4834-A7E8-E080BE454557</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have engineered a recombinant wild-type measles virus which was isolated in Sudan and represents a currently circulating clinically relevant virus. This virus has been tested in the macaque model and has proven to be highly pathogenic, proving our original hypothesis. This will allow us to leverage the techniques developed into others arenas of viral pathogenesis.</gtr:description><gtr:id>0FFC408B-A659-451C-ADE7-D518134423A2</gtr:id><gtr:impact>Colleagues in the Center for Biologics Evaluation and Research (CBER), which is part of the Food and Drug Administration (FDA), are very interested in partering with us in developing an equivalent macaque-based, multidimensional model of disease for mumps. We are currently writing an NIH application to secure funding for these studies.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of a multidimensional model of disease</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have assembled a collection of formalin-fixed tissue blocks, frozen tissues and RNA samples from our monkey studies. This has been done this with a view to facilitating other scientists who may be interested in studying how a vaccine viruse behaves in a natural host compared to the wild-type clinical infection.</gtr:description><gtr:id>BEEFAA72-B926-48CC-8802-BE83F6F026EA</gtr:id><gtr:impact>We have already provided samples to our collaborator in University of W?rzburg collaboration. We plan to make reference to this collection of samples in the first publication which reports the generation of these new recombinant measles viruses. This has now been extended to colleagues in Johns Hopkins University (Baltimore, MD, USA)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pathological samples from vaccinated and virus-infected macaques</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/107CC3C9-3E89-44A5-B8B7-4A336315C81D"><gtr:id>107CC3C9-3E89-44A5-B8B7-4A336315C81D</gtr:id><gtr:title>Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50f37adb683515d150b88f760314d13f"><gtr:id>50f37adb683515d150b88f760314d13f</gtr:id><gtr:otherNames>Ludlow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2DDF04A1-8676-43E9-B1E0-F138DE2F5C83"><gtr:id>2DDF04A1-8676-43E9-B1E0-F138DE2F5C83</gtr:id><gtr:title>Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.</gtr:title><gtr:parentPublicationTitle>Journal of interferon &amp; cytokine research : the official journal of the International Society for Interferon and Cytokine Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b5932a38fb680c266be61b719b6c614"><gtr:id>3b5932a38fb680c266be61b719b6c614</gtr:id><gtr:otherNames>Shivakoti R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1079-9907</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EAFF8077-662A-4AC3-BFD9-010910382D9A"><gtr:id>EAFF8077-662A-4AC3-BFD9-010910382D9A</gtr:id><gtr:title>Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50f37adb683515d150b88f760314d13f"><gtr:id>50f37adb683515d150b88f760314d13f</gtr:id><gtr:otherNames>Ludlow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA1E39FA-F213-4F9D-BEA6-3CEAB3732E1F"><gtr:id>AA1E39FA-F213-4F9D-BEA6-3CEAB3732E1F</gtr:id><gtr:title>Pathological consequences of systemic measles virus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50f37adb683515d150b88f760314d13f"><gtr:id>50f37adb683515d150b88f760314d13f</gtr:id><gtr:otherNames>Ludlow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C87A308C-7C63-46F1-A2EE-43923D6BCA10"><gtr:id>C87A308C-7C63-46F1-A2EE-43923D6BCA10</gtr:id><gtr:title>Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50f37adb683515d150b88f760314d13f"><gtr:id>50f37adb683515d150b88f760314d13f</gtr:id><gtr:otherNames>Ludlow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/144852F8-CFE3-4F0C-B535-E1FE28CBD1A5"><gtr:id>144852F8-CFE3-4F0C-B535-E1FE28CBD1A5</gtr:id><gtr:title>Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b01ed3436b5effd12f5d0b9667c0aab6"><gtr:id>b01ed3436b5effd12f5d0b9667c0aab6</gtr:id><gtr:otherNames>Lemon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A44024D-368A-4AF2-A543-4A95E8B49028"><gtr:id>9A44024D-368A-4AF2-A543-4A95E8B49028</gtr:id><gtr:title>Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c28c456764709352f40d2dd6fba125f"><gtr:id>8c28c456764709352f40d2dd6fba125f</gtr:id><gtr:otherNames>Nguyen DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/139CDDDF-BC58-46A0-953B-0E3B32FE9F74"><gtr:id>139CDDDF-BC58-46A0-953B-0E3B32FE9F74</gtr:id><gtr:title>Measles immune suppression: functional impairment or numbers game?</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b1f0c5868441d6ff83ef687048ca7fb"><gtr:id>5b1f0c5868441d6ff83ef687048ca7fb</gtr:id><gtr:otherNames>de Vries RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D7C7512-51C8-45D7-AADC-B5119D1E7482"><gtr:id>9D7C7512-51C8-45D7-AADC-B5119D1E7482</gtr:id><gtr:title>The pathogenesis of measles.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b1f0c5868441d6ff83ef687048ca7fb"><gtr:id>5b1f0c5868441d6ff83ef687048ca7fb</gtr:id><gtr:otherNames>de Vries RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8503E4D-ABDA-4FB1-883C-6465E0AB5BB1"><gtr:id>C8503E4D-ABDA-4FB1-883C-6465E0AB5BB1</gtr:id><gtr:title>Rinderpest eradication: lessons for measles eradication?</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206e6bfe432f433a7dc924d18a391504"><gtr:id>206e6bfe432f433a7dc924d18a391504</gtr:id><gtr:otherNames>de Swart RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8904A10D-BD2F-4B8F-BF9B-B1990A12F903"><gtr:id>8904A10D-BD2F-4B8F-BF9B-B1990A12F903</gtr:id><gtr:title>New concepts in measles virus replication: getting in and out in vivo and modulating the host cell environment.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/382db645e41c41e93be6344b897e64c5"><gtr:id>382db645e41c41e93be6344b897e64c5</gtr:id><gtr:otherNames>Rima BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5193FDBE-6E41-496E-BD3C-3660A5CC87E7"><gtr:id>5193FDBE-6E41-496E-BD3C-3660A5CC87E7</gtr:id><gtr:title>Early target cells of measles virus after aerosol infection of non-human primates.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b01ed3436b5effd12f5d0b9667c0aab6"><gtr:id>b01ed3436b5effd12f5d0b9667c0aab6</gtr:id><gtr:otherNames>Lemon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C53833A8-FC2A-4C86-BBEA-695D9C1192AA"><gtr:id>C53833A8-FC2A-4C86-BBEA-695D9C1192AA</gtr:id><gtr:title>A prominent role for DC-SIGN+ dendritic cells in initiation and dissemination of measles virus infection in non-human primates.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bbd741ad43e47fba28e25c3cb26ad1c5"><gtr:id>bbd741ad43e47fba28e25c3cb26ad1c5</gtr:id><gtr:otherNames>Mesman AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37F8C4A1-0AAE-49FD-BF5C-1B73B8F11840"><gtr:id>37F8C4A1-0AAE-49FD-BF5C-1B73B8F11840</gtr:id><gtr:title>Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b1f0c5868441d6ff83ef687048ca7fb"><gtr:id>5b1f0c5868441d6ff83ef687048ca7fb</gtr:id><gtr:otherNames>de Vries RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA6EB9BB-3CC0-468F-AAB1-1A5C2AD8CB01"><gtr:id>FA6EB9BB-3CC0-468F-AAB1-1A5C2AD8CB01</gtr:id><gtr:title>In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b1f0c5868441d6ff83ef687048ca7fb"><gtr:id>5b1f0c5868441d6ff83ef687048ca7fb</gtr:id><gtr:otherNames>de Vries RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BDB2CE6-27A1-433A-8367-EB794F3F0415"><gtr:id>3BDB2CE6-27A1-433A-8367-EB794F3F0415</gtr:id><gtr:title>Using the ferret model to study morbillivirus entry, spread, transmission and cross-species infection.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50f37adb683515d150b88f760314d13f"><gtr:id>50f37adb683515d150b88f760314d13f</gtr:id><gtr:otherNames>Ludlow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A205CE2-7B74-4BE9-B2BB-2DBE80CAF6CC"><gtr:id>5A205CE2-7B74-4BE9-B2BB-2DBE80CAF6CC</gtr:id><gtr:title>Paramyxovirus infections in ex vivo lung slice cultures of different host species.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c28c456764709352f40d2dd6fba125f"><gtr:id>8c28c456764709352f40d2dd6fba125f</gtr:id><gtr:otherNames>Nguyen DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A151CBDE-44BF-437D-A924-AD013C8A88C6"><gtr:id>A151CBDE-44BF-437D-A924-AD013C8A88C6</gtr:id><gtr:title>Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78a171c9720b4cd0b5693403afa51065"><gtr:id>78a171c9720b4cd0b5693403afa51065</gtr:id><gtr:otherNames>Munday DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82BC0EE6-D077-479A-9ABA-230D4D09B98E"><gtr:id>82BC0EE6-D077-479A-9ABA-230D4D09B98E</gtr:id><gtr:title>Measles immune suppression: lessons from the macaque model.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b1f0c5868441d6ff83ef687048ca7fb"><gtr:id>5b1f0c5868441d6ff83ef687048ca7fb</gtr:id><gtr:otherNames>de Vries RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801001</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>